These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 9921922)

  • 1. Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer.
    Krepela E; Procházka J; Kárová B; Cermák J; Roubková H
    Neoplasma; 1998; 45(5):318-31. PubMed ID: 9921922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathepsin B, thiols and cysteine protease inhibitors in squamous-cell lung cancer.
    Krepela E; Procházka J; Kárová B; Cermák J; Roubková H
    Neoplasma; 1997; 44(4):219-39. PubMed ID: 9473776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysosomal dipeptidyl-peptidases I and II in human squamous cell lung carcinoma and lung parenchyma.
    Krepela E; Procházka J; Mynaríková H; Kárová B; Cermák J; Roubková H
    Neoplasma; 1996; 43(3):171-8. PubMed ID: 8841504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human recombinant pro-dipeptidyl peptidase I (cathepsin C) can be activated by cathepsins L and S but not by autocatalytic processing.
    Dahl SW; Halkier T; Lauritzen C; Dolenc I; Pedersen J; Turk V; Turk B
    Biochemistry; 2001 Feb; 40(6):1671-8. PubMed ID: 11327826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin B and cysteine proteinase inhibitors in human lung cancer cell lines.
    Heidtmann HH; Salge U; Abrahamson M; Bencina M; Kastelic L; Kopitar-Jerala N; Turk V; Lah TT
    Clin Exp Metastasis; 1997 Jul; 15(4):368-81. PubMed ID: 9219725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple forms of cathepsin B in human lung cancer.
    Krepela E; Procházka J; Mynaríková H; Kárová B; Polák J; Cermák J; Roubková H
    Int J Cancer; 1995 Mar; 61(1):44-53. PubMed ID: 7705933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipeptidyl peptidase IV, prolyl endopeptidase and cathepsin B activities in primary human lung tumors and lung parenchyma.
    Sedo A; Krepela E; Kasafírek E
    J Cancer Res Clin Oncol; 1991; 117(3):249-53. PubMed ID: 1674512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cysteine cathepsins B and L and their inhibitors stefins A and B in carcinoma of the oropharynx: immunohistochemical study.
    Strojan P; Oblak I; Gale N; Smid L; Kos J
    Histopathology; 2008 Nov; 53(5):612-4. PubMed ID: 18983473
    [No Abstract]   [Full Text] [Related]  

  • 9. Cathepsin B activity in human lung tumor cell lines: ultrastructural localization, pH sensitivity, and inhibitor status at the cellular level.
    Spiess E; Brüning A; Gack S; Ulbricht B; Spring H; Trefz G; Ebert W
    J Histochem Cytochem; 1994 Jul; 42(7):917-29. PubMed ID: 8014475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid substitutions in the N-terminal segment of cystatin C create selective protein inhibitors of lysosomal cysteine proteinases.
    Mason RW; Sol-Church K; Abrahamson M
    Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):833-8. PubMed ID: 9480898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of cathepsin L activity by use of the inhibitor CA-074 compared to cathepsin B activity in human lung tumor tissue.
    Werle B; Ebert W; Klein W; Spiess E
    Biol Chem Hoppe Seyler; 1995 Mar; 376(3):157-64. PubMed ID: 7612192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue.
    Friedrich B; Jung K; Lein M; Türk I; Rudolph B; Hampel G; Schnorr D; Loening SA
    Eur J Cancer; 1999 Jan; 35(1):138-44. PubMed ID: 10211102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of cathepsins B and L compared with matrix metalloproteinases and their respective inhibitors in rheumatoid arthritis and osteoarthritis: a parallel investigation by semiquantitative reverse transcriptase-polymerase chain reaction and immunohistochemistry.
    Keyszer G; Redlich A; Häupl T; Zacher J; Sparmann M; Engethüm U; Gay S; Burmester GR
    Arthritis Rheum; 1998 Aug; 41(8):1378-87. PubMed ID: 9704635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cysteine proteinases and their protein inhibitors stefins, cystatins and kininogens.
    Turk V; Brzin J; Kotnik M; Lenarcic B; Popović T; Ritonja A; Trstenjak M; Begić-Odobasić L; Machleidt W
    Biomed Biochim Acta; 1986; 45(11-12):1375-84. PubMed ID: 3495261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Gly-4 of human cystatin A (stefin A) in the binding of target proteinases. Characterization by kinetic and equilibrium methods of the interactions of cystatin A Gly-4 mutants with papain, cathepsin B, and cathepsin L.
    Estrada S; Nycander M; Hill NJ; Craven CJ; Waltho JP; Björk I
    Biochemistry; 1998 May; 37(20):7551-60. PubMed ID: 9585570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential localization of cysteine protease inhibitors and a target cysteine protease, cathepsin B, by immuno-confocal microscopy.
    Calkins CC; Sameni M; Koblinski J; Sloane BF; Moin K
    J Histochem Cytochem; 1998 Jun; 46(6):745-51. PubMed ID: 9603786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cysteine proteinases cathepsins B and K and of cysteine proteinase inhibitor cystatin C in giant cell tumor of tendon sheath.
    Hansen T; Petrow PK; Gaumann A; Keyszer GM; Otto M; Kirkpatrick CJ; Kriegsmann J
    Mod Pathol; 2001 Apr; 14(4):318-24. PubMed ID: 11301348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of potential biological markers cathepsin B, cathepsin L, stefin A and stefin B with urokinase and plasminogen activator inhibitor-1 and clinicopathological data of breast carcinoma patients.
    Levicar N; Kos J; Blejec A; Golouh R; Vrhovec I; Frkovic-Grazio S; Lah TT
    Cancer Detect Prev; 2002; 26(1):42-9. PubMed ID: 12088202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma.
    Budihna M; Strojan P; Smid L; Skrk J; Vrhovec I; Zupevc A; Rudolf Z; Zargi M; Krasovec M; Svetic B; Kopitar-Jerala N; Kos J
    Biol Chem Hoppe Seyler; 1996 Jun; 377(6):385-90. PubMed ID: 8839984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of lysosomal proteinase activities and their expression in rat cultured keratinocytes during differentiation.
    Tanabe H; Kumagai N; Tsukahara T; Ishiura S; Kominami E; Nishina H; Sugita H
    Biochim Biophys Acta; 1991 Sep; 1094(3):281-7. PubMed ID: 1911879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.